Intelligence / Healthtech & medtech market map / Digital health software and connected health technology / Remote monitoring, digital therapeutics and connected-care technology / Pharma and biotech connected clinical-development programs
Pharma and biotech connected clinical-development programs
For pharmaceutical and biotechnology companies that need to capture patient-generated data, support protocol execution, monitor safety or adherence, and provide therapy-linked patient support, particularly when decentralized trials, continuous-data requirements, or post-approval evidence needs trigger connected-care procurement. Excludes systems bought directly by providers or payers.
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Pharmaceutical and biotechnology companies
- Buying centre
- Clinical development, digital health, medical affairs, pharmacovigilance, and health economics and outcomes research define use cases and evidence requirements. Information technology, security, quality, legal, regulatory, procurement, and external-innovation teams evaluate platforms and connected d
- Need to recruit or retain patients in clinical trials
- Protocols requiring continuous data outside research sites
- Safety, adherence, or real-world evidence requirements
- Therapy launch or post-approval patient-support programs
- Fragmented patient-generated and clinical-trial data
- High site workload and inconsistent execution across protocols
- Consent, privacy, validation, and regulatory complexity
- Slow integration with trial systems and existing clinical workflows
How this was sized
Not sized yet
No cited source quantifies connected-care spending by pharmaceutical and biotechnology buyers or separates clinical-development and post-approval use cases. The connected-health-platform source identifies vendors serving virtual care, device-anchored remote monitoring, analytics, and infrastructure, but provides no buyer-segment allocation [10]. Scores use a 1-5 scale, with 5 highest.
- Connected Health Platform Market Size, Share & Forecast Report 2025 to 2034 | Dataintelo
dataintelo.com · 2025-09-30
Alongside it in Remote monitoring, digital therapeutics and connected-care technology
// Sell into Pharma and biotech connected clinical-development programs